Ritsukou Tei
Itabashi, 1738610, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Canagliflozin Improves Erythropoiesis in Diabetes Patients with Anemia of Chronic Kidney Disease.
Journal: Diabetes technology & therapeutics
Published: August 07, 2019
Prevalence of Carnitine Deficiency and Decreased Carnitine Levels in Patients on Hemodialysis.
Journal: Blood purification
Published: April 04, 2019
Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial.
Journal: European journal of clinical nutrition
Published: July 09, 2018
Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial.
Journal: Diabetes & vascular disease research
Published: June 21, 2018
Efficacy and safety of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in hemodialysis patients with diabetic nephropathy: A randomized open-label prospective trial.
Journal: Diabetes research and clinical practice
Published: February 22, 2016
Randomized Controlled Trial of Darbepoetin α Versus Continuous Erythropoietin Receptor Activator Injected Subcutaneously Once Every Four Weeks in Patients with Chronic Kidney Disease at the Pre-Dialysis Stage.
Journal: International journal of molecular sciences
Published: October 07, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026